Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) — Net Asset Momentum
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) recorded a net asset momentum of 7.3% as of December 2025, with net assets of CN¥781.08 Million CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is Gansu Longshenrongfa Pharmaceutical Indu's equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Net Asset Momentum (2011–2025)
This chart tracks Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is +7.3%, with net assets of CN¥781.08 Million CNY as of December 2025. Read how much debt does Gansu Longshenrongfa Pharmaceutical Indu carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
The table below shows the complete annual net asset history for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 300534 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥781.08 Million | CN¥1.39 Billion | CN¥613.42 Million | ▲ +7.3% |
| 2024 | CN¥727.93 Million | CN¥1.40 Billion | CN¥674.39 Million | ▲ +2.3% |
| 2023 | CN¥711.51 Million | CN¥1.34 Billion | CN¥625.14 Million | ▼ -6.8% |
| 2022 | CN¥763.13 Million | CN¥912.79 Million | CN¥149.66 Million | ▲ +4.1% |
| 2021 | CN¥732.84 Million | CN¥824.07 Million | CN¥91.24 Million | ▼ -0.9% |
| 2020 | CN¥739.13 Million | CN¥866.66 Million | CN¥127.53 Million | ▲ +0.0% |
| 2019 | CN¥738.88 Million | CN¥810.15 Million | CN¥71.26 Million | ▲ +2.5% |
| 2018 | CN¥720.83 Million | CN¥778.51 Million | CN¥57.68 Million | ▲ +1.2% |
| 2017 | CN¥712.19 Million | CN¥782.23 Million | CN¥70.04 Million | ▲ +1.2% |
| 2016 | CN¥703.74 Million | CN¥763.48 Million | CN¥59.74 Million | ▲ +73.5% |
| 2015 | CN¥405.57 Million | CN¥646.74 Million | CN¥241.17 Million | ▲ +11.7% |
| 2014 | CN¥363.10 Million | CN¥478.49 Million | CN¥115.40 Million | ▲ +13.9% |
| 2013 | CN¥318.92 Million | CN¥453.96 Million | CN¥135.04 Million | ▲ +86.0% |
| 2012 | CN¥171.46 Million | CN¥294.53 Million | CN¥123.07 Million | ▲ +278.1% |
| 2011 | CN¥45.35 Million | CN¥120.49 Million | CN¥75.15 Million | — |